109 related articles for article (PubMed ID: 17573400)
21. Q: Should N-acetylcysteine be used routinely to prevent contrast-induced acute kidney injury?
Sivalingam SK; Hariharan MV; Braden GL; Freda BJ
Cleve Clin J Med; 2012 Nov; 79(11):746-9. PubMed ID: 23125323
[No Abstract] [Full Text] [Related]
22. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
ACT Investigators
Circulation; 2011 Sep; 124(11):1250-9. PubMed ID: 21859972
[TBL] [Abstract][Full Text] [Related]
23. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
[TBL] [Abstract][Full Text] [Related]
24. In search of an algorithm to prevent acute kidney injury.
Dauerman HL
JACC Cardiovasc Interv; 2009 Nov; 2(11):1125-7. PubMed ID: 19926055
[No Abstract] [Full Text] [Related]
25. [Absence of nephro-protective effect of acetylcysteine in patients with chronic renal failure investigated by coronary angiography].
El Mahmoud R; Le Feuvre C; Le Quan Sang KH; Helft G; Beygui F; Batisse JP; Metzger JP
Arch Mal Coeur Vaiss; 2003 Dec; 96(12):1157-61. PubMed ID: 15248440
[TBL] [Abstract][Full Text] [Related]
26. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
[TBL] [Abstract][Full Text] [Related]
27. N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency.
Wijeysundera DN; Beattie WS; Rao V; Granton JT; Chan CT
Can J Anaesth; 2007 Nov; 54(11):872-81. PubMed ID: 17975231
[TBL] [Abstract][Full Text] [Related]
28. Effects of dexpanthenol and N-acetylcysteine pretreatment in rats before renal ischemia/reperfusion injury.
Sen H; Deniz S; Yedekci AE; Inangil G; Muftuoglu T; Haholu A; Ozkan S
Ren Fail; 2014 Nov; 36(10):1570-4. PubMed ID: 25156619
[TBL] [Abstract][Full Text] [Related]
29. Of hypes and hopes: N-acetylcysteine and cystatin C.
Schultz MJ; Royakkers AA; Bouman CS
AJR Am J Roentgenol; 2008 Mar; 190(3):W224; author reply W225. PubMed ID: 18287418
[No Abstract] [Full Text] [Related]
30. Contrast-Induced Acute Kidney Injury: Comparison of Preventative Therapies.
Honicker T; Holt K
Nephrol Nurs J; 2016; 43(2):109-16; quiz 117. PubMed ID: 27254966
[TBL] [Abstract][Full Text] [Related]
31. A double-blind, randomized, controlled trial on N-acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.
Ataei S; Hadjibabaie M; Moslehi A; Taghizadeh-Ghehi M; Ashouri A; Amini E; Gholami K; Hayatshahi A; Vaezi M; Ghavamzadeh A
Hematol Oncol; 2015 Jun; 33(2):67-74. PubMed ID: 24711000
[TBL] [Abstract][Full Text] [Related]
32. Acetylcysteine for prevention of contrast nephropathy: meta-analysis.
Birck R; Krzossok S; Markowetz F; Schnülle P; van der Woude FJ; Braun C
Lancet; 2003 Aug; 362(9384):598-603. PubMed ID: 12944058
[TBL] [Abstract][Full Text] [Related]
33. [Use of N-acetylcysteine prior to cardiac catheterization to prevent acute renal injury in patients with stage III chronic kidney disease].
Shavit L; Lifschitz M; Lachish T; Rosenmann D; Balkin J; Slotki I
Harefuah; 2007 Sep; 146(9):655-9, 736. PubMed ID: 17969299
[TBL] [Abstract][Full Text] [Related]
34. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial.
Sisillo E; Ceriani R; Bortone F; Juliano G; Salvi L; Veglia F; Fiorentini C; Marenzi G
Crit Care Med; 2008 Jan; 36(1):81-6. PubMed ID: 18090169
[TBL] [Abstract][Full Text] [Related]
35. N-acetylcysteine to prevent contrast nephropathy.
Meine TJ; Washam JB
Am Heart J; 2004 Mar; 147(3):440-1. PubMed ID: 14999191
[No Abstract] [Full Text] [Related]
36. [Prevention of contrast-induced acute kidney injury].
Guastoni C; De Servi S; Covella P; Turri C; Gidaro B; Bellotti N; Stasi A
G Ital Nefrol; 2012; 29 Suppl 58():S33-45. PubMed ID: 23229601
[TBL] [Abstract][Full Text] [Related]
37. N-acetylcysteine (NAC) protects against acute kidney injury (AKI) following prolonged pneumoperitoneum in the rat.
Seguro AC; Poli de Figueiredo LF; Shimizu MH
J Surg Res; 2012 Jun; 175(2):312-5. PubMed ID: 21764077
[TBL] [Abstract][Full Text] [Related]
38. N-acetylcysteine and acute renal failure: are we doing too little too late?
Rachoin JS
Crit Care Med; 2011 Nov; 39(11):2574-5. PubMed ID: 22005235
[No Abstract] [Full Text] [Related]
39. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury.
Drager LF; Andrade L; Barros de Toledo JF; Laurindo FR; Machado César LA; Seguro AC
Nephrol Dial Transplant; 2004 Jul; 19(7):1803-7. PubMed ID: 15128882
[TBL] [Abstract][Full Text] [Related]
40. Sodium ferric gluconate causes oxidative stress but not acute renal injury in patients with chronic kidney disease: a pilot study.
Leehey DJ; Palubiak DJ; Chebrolu S; Agarwal R
Nephrol Dial Transplant; 2005 Jan; 20(1):135-40. PubMed ID: 15522899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
